By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is neutral, with concerns raised about Hyperliquid's (HYPE) buyback sustainability, dilution risk, and potential infrastructure issues. While some panelists acknowledge XRP's regulatory risks, they also see long-term potential.
Risk: Dilution risk from monthly token issuance in HYPE, potentially eroding its 'floor' even with sustained volumes.
Opportunity: Regulatory clarity for XRP, which could trigger institutional reallocation and a significant re-rating.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
HYPE trades close to its record high around $77 while XRP trades near $1.13 and flat on the week.
XRP ETFs hold about $994 million in net assets to HYPE ETFs' $221 million, but HYPE has pulled in roughly $50 million so far this month against XRP's $24 million, so the smaller fund is growing faster.
HYPE's ETF demand is backed by a buyback engine, as Hyperliquid earns well over a billion dollars a year in trading fees, and almost all of it automatically buys HYPE off the market, which is why analysts value it more like a stock than a token.
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
A year ago, you couldn't buy either of these cryptocurrencies in a normal brokerage account. Now, both XRP (CRYPTO:XRP) and Hyperliquid have spot ETFs trading on U.S. exchanges, both coins rank among the top 10, and if you want regulated exposure to one of them, you have to pick a side.
However, deciding the best one to buy is trickier than it looks. One fund is the established giant with nearly a billion dollars behind it, and the other is a newcomer, which is a fraction of its size. The obvious move is to go with the bigger, safer one. But the money flowing into these two funds points the other way right now, and that's worth understanding before you choose.
So, which one actually deserves your money today, the proven XRP ETFs or the fast-rising HYPE ETFs from Hyperliquid—the biggest on-chain exchange for crypto derivatives?
XRP ETFs Dwarf HYPE ETFs in Size
The size gap between both crypto’s ETF is wide. XRP's spot ETFs hold about $994 million in net assets and have pulled in $1.45 billion in total since launching in November 2025. HYPE's funds, which only opened in May, hold around $221 million. So, the XRP products are roughly four and a half times bigger.
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Moreover, there are five XRP ETF funds now, with names like Franklin Templeton and Bitwise behind them, and eight months of trading history showing the money stays put. For an everyday investor, that means deep liquidity and there’s a quiet confidence that the fund will still be running smoothly years from now. HYPE, on the other hand, has three funds and roughly two trading months on the board, so it simply hasn't had time to prove itself.
Another thing that mostly won't decide this for you is cost. Most of these funds charge somewhere around 0.30% a year, so for the typical pick on either XRP or HYPE, you're not paying a meaningful premium one way or the other.
Metric
XRP ETFs
HYPE ETFs
Net assets
$994 million
$221 million
Total inflows
$1.45 billion
$183 million
Launched
November 2025
May 2026
Number of funds
5
3
Annual fee range
0.19%–0.50%
0.29%–0.34%
Money Is Flowing Into HYPE Faster
So far this month, HYPE's ETFs have taken in around $50 million, while XRP's have brought in closer to $24 million, even though the XRP funds are several times bigger. XRP's inflows have cooled off from the bigger weeks it saw back in May, just as HYPE's have picked up speed.
Hyperliquid takes in well over a billion dollars a year in trading fees, and almost all of that money goes straight back into buying HYPE off the open market every single day. That steady, built-in buying is why some analysts treat the token more like a stock doing buybacks than a typical crypto coin, and it's what the ETF money is really betting on.
That said, it doesn’t mean XRP's slower inflows are dead money. Those buying XRP ETFS are more patient—the institutional money that started showing up after XRP's long legal fight with regulators ended in 2025.
The catch with HYPE’s ETFs is that it's early. The funds are tiny and only a couple of months old, so the hot streak can fade once the novelty wears off. More so, Hyperliquid also releases new tokens to its team every month, which the buybacks have to keep soaking up.
HYPE Trades Near Its High While XRP Stays Flat
The ETFs are only half the picture, because the two coins are in very different spots right now. HYPE trades near $70, up about 19% over the past week and not far off the record high around $77 it set in mid-June. XRP trades near $1.13, flat on the week and down roughly 16% over the month—still a long way below its old peaks.
Buying a HYPE ETF means stepping in while the coin is near the top of a strong run, where the upside is more momentum but the obvious risk is a pullback. Buying an XRP ETF means picking up a quiet, beaten-down coin that the crowd has mostly walked away from, where the risk is that it stays cheap and ignored, though a lot of that disappointment is already baked into the low price.
Which ETF Should You Actually Buy?
There's no single winner here, because the two cryptocurrencies aren't the same bet. The right pick depends on matching the fund to the investor you are. If you want size, a long track record, and something you can hold without checking it every week, the XRP ETFs are the steadier choice. If you can stomach a small, young fund trading near its high in exchange for faster growth and a revenue engine behind the token, the HYPE ETFs give you that.
What decides whether HYPE keeps earning the current inflows is if people keep trading on Hyperliquid in the same volumes, because that trading is what funds the buybacks holding the whole thing up. XRP ETF inflows don't chase momentum, so the catalyst to watch is the CLARITY Act passing, which could skyrocket its institutional adoption.
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Four leading AI models discuss this article
"Neither option is a clear winner; XRP ETFs offer durability and liquidity, while HYPE ETFs offer upside via a buyback engine that hinges on sustained volumes and token issuance controls."
XRP ETFs look more durable on size and history; HYPE offers faster upside but with fragility. The strongest counterpoint is that Hyperliquid’s buybacks depend on $1B+ annual trading fees—if volumes slip, the engine stalls, and new token issuances monthly threaten dilution. Liquidity depth, market stress performance, and redemption mechanics are underplayed: a tiny fund with a buyback gimmick can trade at elevated premiums, but that may break in a regime shift. Regulators’ stance on crypto derivatives and the CLARITY Act remains uncertain, and XRP's longer-term upside hinges on regulatory clarity, not just ETF flows.
The strongest counterpoint to neutrality is that HYPE's growth engine could prove durable: if Hyperliquid sustains trading volumes and token issuance remains predictable, the buyback-driven support could beat the slower, 'buy-and-hold' XRP ETFs over time. The article underestimates how quickly 'stock-like' demand can compound in a hot crypto derivatives market.
"HYPE’s buyback-driven valuation is a pro-cyclical trap that masks the risk of declining trading volumes and aggressive token dilution."
The article frames this as a choice between legacy stability and momentum, but it misses the structural risk in Hyperliquid’s 'buyback engine.' While HYPE’s revenue-driven buybacks create a synthetic floor, they are inherently pro-cyclical; if crypto derivatives volume craters, the buyback support vanishes exactly when the token needs it most. Conversely, XRP’s stagnation isn't just 'patience'—it’s a lack of utility-driven demand post-legal clarity. XRP is a regulatory play effectively priced for mediocrity, while HYPE is a levered bet on exchange volume. I’m skeptical of HYPE at record highs, as the 'stock-like' valuation ignores that token emission schedules often outpace buyback capacity during market corrections.
If Hyperliquid’s decentralized exchange continues to capture market share from centralized incumbents, the buyback-to-emission ratio could remain net-positive, creating a self-reinforcing flywheel that defies traditional valuation metrics.
"HYPE's revenue-backed buyback structure is economically distinct from XRP's regulatory-bet profile, but the article conflates them as equivalent choices when they require opposite risk tolerances and time horizons."
This article frames a false choice between two fundamentally different assets masquerading as comparable ETF options. HYPE's $1B+ annual fee revenue and mandatory buyback mechanism creates a structural floor that resembles a dividend aristocrat more than a speculative token—but the article buries the real risk: Hyperliquid's token issuance to the team dilutes holders monthly, and buyback sustainability hinges entirely on trading volumes that could evaporate in a market downturn. XRP's 16% monthly decline looks like capitulation, but the article ignores that regulatory clarity (CLARITY Act) could trigger institutional reallocation that the current $994M AUM can't absorb without massive re-rating. The article's 'pick your investor type' conclusion avoids the harder question: which has actual cash flow backing it?
HYPE's buyback model only works if Hyperliquid maintains billion-dollar annual volumes—a single market shock could crater trading activity and expose the token as purely speculative, while XRP's regulatory tailwinds are priced in already and the CLARITY Act may disappoint.
"HYPE's buyback model faces unquantified dilution pressure from ongoing team token releases that the article downplays."
The article highlights HYPE's faster recent inflows and automatic buybacks funded by over $1B in annual Hyperliquid fees as reasons to favor its ETFs over larger XRP products. Yet this overlooks dilution risk from monthly team token releases that buybacks must continuously absorb, plus the fact that HYPE trades near $77 highs while volumes could contract sharply in a crypto downturn. XRP's post-2025 regulatory clarity may unlock slower but larger institutional allocations once the CLARITY Act advances. HYPE's edge looks momentum-driven rather than structurally durable at current levels.
If Hyperliquid trading volumes expand 30-50% YoY, the buyback engine could easily outpace team releases and sustain premiums even near highs.
"Worst-case dilution outpaces buybacks and a volume shock can erase the 'floor' on HYPE"
Claude has a point on dilution and buyback sustainability. But the article underplays the levered dilution risk: monthly token issuance effectively erodes any 'floor' even if volumes hold, since new supply expands faster than buybacks can neutralize. In a cyclical downturn, volumes collapse and the premium could snap back toward zero. The piece should quantify worst-case dilution vs. buyback capacity and test a volume shock scenario.
"Hyperliquid's buyback model ignores the underlying L1 infrastructure risk which is more critical than token dilution mechanics."
Claude and ChatGPT are fixated on the buyback-to-dilution ratio, but they miss the real systemic risk: Hyperliquid’s L1 infrastructure. If the network experiences a validator outage or a major bridge exploit, the 'dividend' stops instantly regardless of volume. XRP, for all its stagnation, is battle-tested on ledger security. We are comparing a high-yield, high-risk synthetic derivative to a legacy infrastructure play. The 'floor' is an illusion; both assets are effectively long-volatility bets.
"Infrastructure risk is real but secondary to volume sustainability; HYPE's floor collapses on trading activity, not validator outages."
Gemini's infrastructure risk is real but overstated. Hyperliquid's validator outage risk exists, yes—but XRP's 'battle-tested' ledger doesn't solve the actual problem: zero utility-driven demand post-Ripple settlement. Both are long-volatility bets, agreed. But the dilution math still matters more than network risk here. If HYPE volumes hold at $1B+, buybacks absorb team releases. If they don't, the token collapses regardless of ledger uptime. That's the sequencing Gemini skipped.
"Infrastructure failure would simultaneously halt volumes and expose dilution without buyback support."
Claude's sequencing assumes volumes can be isolated from network stability, yet a validator outage or bridge exploit would immediately slash trading fees and buyback capacity while team emissions continue unabated. This compounds the dilution risk he flags rather than standing apart from it. Gemini correctly identifies the precondition Gemini's infrastructure point isn't peripheral—it determines whether the $1B fee threshold ever holds under stress.
The panel consensus is neutral, with concerns raised about Hyperliquid's (HYPE) buyback sustainability, dilution risk, and potential infrastructure issues. While some panelists acknowledge XRP's regulatory risks, they also see long-term potential.
Regulatory clarity for XRP, which could trigger institutional reallocation and a significant re-rating.
Dilution risk from monthly token issuance in HYPE, potentially eroding its 'floor' even with sustained volumes.